Identifying copyright holders and response times are major challenges in COA licensing, causing delays in clinical trials. Clear documentation of copyright ownership and standardized response times ...
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
As industries intensify their efforts to cut downtime, reduce maintenance costs and operate with greater energy efficiency, the ability to anticipate equipment issues before they occur has become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback